Is China Pharma Holdings Inc halal to invest in?

According to Musaffa's Shariah screening methodology, China Pharma Holdings Inc (CPHI) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is China Pharma Holdings Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes China Pharma Holdings Inc using these criteria to determine its compliance status.

Can Muslims buy shares of China Pharma Holdings Inc?

Muslim investors may consider investing in China Pharma Holdings Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is China Pharma Holdings Inc classified as NOT HALAL?

Musaffa determines the Shariah status of China Pharma Holdings Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for China Pharma Holdings Inc updated?

The Shariah compliance status of China Pharma Holdings Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like China Pharma Holdings Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of China Pharma Holdings Inc?

You can check the latest Shariah compliance status of China Pharma Holdings Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

CPHI Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: April 03, 2026

Report Source: 2025 Annual Report

China Pharma Holdings Inc. Stock Analysis CPHI

United States Health Care Nano Cap Report: 2025 Annual

China Pharma Holdings, Inc. engages in the development, manufacture, and marketing of pharmaceutical products. The company is headquartered in Haikou, Hainan and currently employs 215 full-time employees. The company went IPO on 2000-02-15. The firm is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for high-incidence and high-mortality diseases and medical conditions prevalent in the PRC. The firm's products include dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The firm's products and solutions are mainly applied in the treatment of various diseases and medical conditions. The firm mainly operates in the domestic market.

Key Statistics of China Pharma Holdings Inc (CPHI)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.99$1.22

Today's Open

$0.99

Volume

144.07K

P/E Ratio (TTM)

52 Week Range

$0.38$2.60

Market Cap

22.38M

Avg. Volume

657.21K

Dividend Yield

Financial Metrics & Statements of China Pharma Holdings Inc (CPHI)

FAQ's for China Pharma Holdings Inc (CPHI)

According to Musaffa’s Shariah screening methodology, China Pharma Holdings Inc (CPHI) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.